MAIA under the microscope - bringing trial design into focus

Nat Rev Clin Oncol. 2019 Jun;16(6):339-340. doi: 10.1038/s41571-019-0198-0.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Clinical Trials, Phase III as Topic
  • Dexamethasone / therapeutic use
  • Humans
  • Lenalidomide / therapeutic use
  • Multiple Myeloma / drug therapy*
  • Progression-Free Survival
  • Randomized Controlled Trials as Topic
  • Research Design
  • Standard of Care
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • daratumumab
  • Dexamethasone
  • Lenalidomide